Modulo Bio logo — Brain health for life.

Modulo Bio

Brain health for life.

Founded 2021 11 employees Seed Total: $8.00M Biotechnology

General Information

Company Name Modulo Bio
Founded Year 2021
Employees 11
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Modulo Bio. To contact Modulo Bio, visit modulo.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Modulo Bio compare?

A PDF of Modulo Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Modulo Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Modulo Bio

Modulo Bio is a biotechnology startup, founded in 2020, with a mission to reprogram the brain’s immune system to cure neurodegenerative disorders. The company has recently secured an impressive $8.00M in its Seed Round investment on 01 June 2023. The investors participating in this round include prominent names such as Builders VC, Initialized Capital, Refactor Capital, Spacecadet Ventures, Cantos Ventures, Bioverge Ventures, and Hawktail Management. Modulo Bio's slogan "Brain health for life" aptly captures its innovative approach towards addressing neurological health challenges. With this recent funding, the company is poised to make significant strides in revolutionizing the treatment of neurodegenerative disorders.

Taxonomy: brain health, neurodegenerative disorders, brain reprogramming, immune system, neuroscience

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $8.00M 7
Builders VC, Initialized Capital +5
01 Jun 2023

Modulo Bio Alternatives & Competitors

View All Alternatives
Modulo Bio vs
Neumora
Neumora United States

Pioneering a new era of medicines for brain diseases

Series B
111 employees
Biotechnology, Health Care
Modulo Bio vs
Alector
Alector United States

We are on a mission to make brain disorders history.

IPO
141 employees
Biotechnology, Health Care
Modulo Bio vs

Pioneering immune-regulating medicines to combat cancer, autoimmune diseases, and neurodegenerative...

1 employees
Biotechnology, Pharmaceutical

FAQ About Modulo Bio

Brain health for life.
Modulo Bio was founded in 2021.
Modulo Bio operates in Biotechnology. Its work centres on brain health, neurodegenerative disorders, brain reprogramming and immune system.
Modulo Bio has approximately 11 employees.
Modulo Bio has completed 1 funding round, raising a total of $8.00M. The latest funding stage is Seed.
Top alternatives and competitors to Modulo Bio include Neumora, Alector, Immunophage Biotech, Neurologix, Georgiamune Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Modulo Bio and Neumora are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Modulo Bio, https://bouncewatch.com/company/modulo-bio, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes